Accelerating your drug development and approval
Drug development & approval


Pharmavize is using dry and wet milling techniques to reduce the particle size or your drug candidate. Nanonization will increase the surface-to-volume ratio of APIs which may result in a better API solubilization and hence increasing drug bio-availability.

Essential API properties for applying this technology:
Preferably, APIs have a high melting point. Wet milling may use surfactants and hence APIs should be surfactant compatible.

Minimum amount of API needed for feasibility study:
500 mg